EA201492104A1 - Ингибитор jak1/2 - Google Patents
Ингибитор jak1/2Info
- Publication number
- EA201492104A1 EA201492104A1 EA201492104A EA201492104A EA201492104A1 EA 201492104 A1 EA201492104 A1 EA 201492104A1 EA 201492104 A EA201492104 A EA 201492104A EA 201492104 A EA201492104 A EA 201492104A EA 201492104 A1 EA201492104 A1 EA 201492104A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- jak1
- inhibitor
- jak2
- cancer
- accordingly
- Prior art date
Links
- 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 title abstract 2
- 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 abstract 1
- -1 aminopyrazole compound Chemical class 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261659679P | 2012-06-14 | 2012-06-14 | |
| PCT/US2013/044211 WO2013188184A1 (en) | 2012-06-14 | 2013-06-05 | Inhibitor of jak1 and jak2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201492104A1 true EA201492104A1 (ru) | 2015-06-30 |
Family
ID=48626679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201492104A EA201492104A1 (ru) | 2012-06-14 | 2013-06-05 | Ингибитор jak1/2 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9062050B2 (enExample) |
| EP (1) | EP2861231B1 (enExample) |
| JP (1) | JP6092376B2 (enExample) |
| KR (1) | KR20150008907A (enExample) |
| CN (1) | CN104349775B (enExample) |
| AU (1) | AU2013274641B2 (enExample) |
| BR (1) | BR112014030651A2 (enExample) |
| CA (1) | CA2871659C (enExample) |
| EA (1) | EA201492104A1 (enExample) |
| ES (1) | ES2605827T3 (enExample) |
| IN (1) | IN2014MN02228A (enExample) |
| MX (1) | MX2014015271A (enExample) |
| WO (1) | WO2013188184A1 (enExample) |
| ZA (1) | ZA201407940B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR105400A1 (es) * | 2015-08-04 | 2017-09-27 | Lilly Co Eli | Inhibidores de jak1 |
| AU2020242287A1 (en) | 2019-03-21 | 2021-09-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A Dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| CN110229067A (zh) * | 2019-06-05 | 2019-09-13 | 南京焕然生物科技有限公司 | 一种2-氨基茚制备方法 |
| KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| CN115141195B (zh) * | 2021-03-03 | 2024-02-06 | 成都先导药物开发股份有限公司 | 一种nuak抑制剂及其用途 |
| WO2023086320A1 (en) * | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | Forms and compositions of inhibitors of jak2 |
| CN116585312A (zh) * | 2023-04-30 | 2023-08-15 | 兰州大学第二医院 | 含苯氧基丙酸化合物的胰腺癌jak2和stat3双靶向抑制剂及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006087530A1 (en) | 2005-02-16 | 2006-08-24 | Astrazeneca Ab | Chemical compounds |
| TWI398252B (zh) * | 2006-05-26 | 2013-06-11 | Novartis Ag | 吡咯并嘧啶化合物及其用途 |
| US20100204246A1 (en) * | 2007-04-18 | 2010-08-12 | Astrazeneca Ab | 5-aminopyrazol-3-yl-3h-imidazo (4,5-b) pyridine derivatives and their use for the treatment of cancer |
-
2013
- 2013-06-05 AU AU2013274641A patent/AU2013274641B2/en not_active Ceased
- 2013-06-05 EA EA201492104A patent/EA201492104A1/ru unknown
- 2013-06-05 WO PCT/US2013/044211 patent/WO2013188184A1/en not_active Ceased
- 2013-06-05 KR KR20147034683A patent/KR20150008907A/ko not_active Abandoned
- 2013-06-05 EP EP13729215.7A patent/EP2861231B1/en not_active Not-in-force
- 2013-06-05 CA CA2871659A patent/CA2871659C/en not_active Expired - Fee Related
- 2013-06-05 BR BR112014030651A patent/BR112014030651A2/pt not_active IP Right Cessation
- 2013-06-05 CN CN201380031385.1A patent/CN104349775B/zh not_active Expired - Fee Related
- 2013-06-05 ES ES13729215.7T patent/ES2605827T3/es active Active
- 2013-06-05 JP JP2015517311A patent/JP6092376B2/ja not_active Expired - Fee Related
- 2013-06-05 MX MX2014015271A patent/MX2014015271A/es unknown
- 2013-06-05 IN IN2228MUN2014 patent/IN2014MN02228A/en unknown
- 2013-06-05 US US14/402,146 patent/US9062050B2/en not_active Expired - Fee Related
-
2014
- 2014-10-30 ZA ZA2014/07940A patent/ZA201407940B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013274641A1 (en) | 2014-11-20 |
| US9062050B2 (en) | 2015-06-23 |
| KR20150008907A (ko) | 2015-01-23 |
| CA2871659C (en) | 2017-04-04 |
| MX2014015271A (es) | 2015-03-05 |
| BR112014030651A2 (pt) | 2017-06-27 |
| CA2871659A1 (en) | 2013-12-19 |
| CN104349775A (zh) | 2015-02-11 |
| AU2013274641B2 (en) | 2015-09-24 |
| EP2861231A1 (en) | 2015-04-22 |
| WO2013188184A1 (en) | 2013-12-19 |
| ES2605827T3 (es) | 2017-03-16 |
| EP2861231B1 (en) | 2016-08-31 |
| JP2015519396A (ja) | 2015-07-09 |
| ZA201407940B (en) | 2016-05-25 |
| JP6092376B2 (ja) | 2017-03-08 |
| US20150133490A1 (en) | 2015-05-14 |
| CN104349775B (zh) | 2017-06-06 |
| IN2014MN02228A (enExample) | 2015-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019501321B1 (en) | Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders | |
| PH12018500041A1 (en) | Substituted aza compoounds as irak-4 inhibitors | |
| MX2013011329A (es) | Combinaciones de compuestos inhibidores de akt y erlotinib y metodos de uso. | |
| EA201492104A1 (ru) | Ингибитор jak1/2 | |
| PH12018502102A1 (en) | Pyrrolotriazine compounds as tam inhibitors | |
| NZ729005A (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| UA111382C2 (uk) | Інгібітори протеїнкінази | |
| JO3148B1 (ar) | مركب مثبط لإشارات مسار notch | |
| EA201400412A1 (ru) | ЗАМЕЩЕННЫЕ БЕНЗИЛИНДАЗОЛЫ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Bub1 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ | |
| SA515360469B1 (ar) | مركبات حلقية غير متجانسة لتثبيط إنزيم جلوتاميناز والطرق الخاصة باستخدامها | |
| EA201890307A1 (ru) | Индазольные и азаиндазольные соединения как ингибиторы irak-4 | |
| EA201591509A1 (ru) | Ингибиторы cdc7 | |
| PH12015500064B1 (en) | Imidazotriazinecarbonitriles useful as kinase inhibitors | |
| EA201591913A1 (ru) | Ингибиторы протеинкиназы | |
| MX381994B (es) | Inhibidor de janus quinasa. | |
| MX389105B (es) | Inhibidor de quinasas reordenadas durante la transfeccion (ret). | |
| EA201170834A1 (ru) | Соединения, пригодные для ингибирования chk1 | |
| EA201391208A1 (ru) | КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ С ПРИМЕНЕНИЕМ ИНГИБИТОРОВ mTOR/JAK | |
| PH12015502031A1 (en) | Tetrahydropyrrolothiazine compounds | |
| EA201690513A1 (ru) | Комбинация ингибитора mek и ингибитора erk для применения в лечении гиперпролиферативных заболеваний | |
| EA201300610A1 (ru) | Хиназолинкарбоксамидазетидины | |
| PH12019501022A1 (en) | Pyrazolopyrimidine compounds and methods of use thereof | |
| EA201590552A1 (ru) | Аминохинолины в качестве ингибиторов киназы | |
| EA201692470A1 (ru) | Фармацевтические комбинации | |
| EA201390499A1 (ru) | Соединения, подходящие для ингибирования снк1 |